Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction∗∗A complete list of the TAMI Study Group appears in J Am Coll Cardiol 1992;19:482–489.

This publication has 20 references indexed in Scilit:

• Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction
  Cardiovascular Research, 1990
• Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog.
  Circulation, 1990
• A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction
  The American Journal of Cardiology, 1989
• Estimation of acute myocardial infarct size in man by serum CK-MB measurements.
  Circulation, 1982
• The creatine kinase curve area and peak creatine kinase after acute myocardial infarction: Usefulness and limitations
  American Heart Journal, 1981
• The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion.
  Circulation, 1977
• An improved basis for enzymatic estimation of infarct size.
  Circulation, 1975
• A sensitivity analysis of enzymatic estimation of infarct size.
  Circulation, 1975
• Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.
  Circulation, 1975
• Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity
  Journal of Clinical Investigation, 1971